Glaxosmithkline Pharmaceuticals informs about board meeting

04 Feb 2019 Evaluate

Glaxosmithkline Pharmaceuticals has informed about a meeting of the Board of Directors of the Company was held today i.e. 4th February, 2019. Pursuant to Clause 33 read with Clause 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, the Company has enclosed herewith the Un-Audited Standalone Financial Results and Limited Review Report for the quarter and nine months ended 31st December, 2018. Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, the Board of Directors at its meeting held today have re-appointed Annaswamy Vaidheesh (DIN No: 01444303) as Managing Director of the Company for period from 1st October, 2019 to 31st March 2020. A Brief profile of Annaswamy Vaidheesh is enclosed as Annexure.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2329.60 -19.10 (-0.81%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×